Lymphoedema can occur secondary to treatment for cancer. It is currently diagnosed using methods which do not allow for early diagnosis, allowing significant tissue damage to occur before treatment is commenced. The aim of this research proposal is to improve the detection and diagnosis of lymphoedema so that it can be treated as early as possible, preventing permanent tissue damage and potentially improving prognosis.
Development Of A Magnetic Resonance Imaging (MRI) Platform To Evaluate Neuroprotective And Regenerative Therapies In MS
Funder
National Health and Medical Research Council
Funding Amount
$116,667.00
Summary
Multiple Sclerosis (MS) involves inflammation and damage to nerve cells. New therapies are needed to minimize and reverse nerve cell damage. Currently, ways to judge the benefit of these therapies are primitive. We propose that assessing the benefits of these treatments in optic neuritis (inflammation of the eye nerve) is the way forward but first, we need to develop reliable tests to measure these treatments. This application proposes to use magnetic resonance imaging (MRI) for this purpose.
Acute And Chronic Stroke - Novel Imaging Biomarkers Of The Ischemic Penumbra And Recovering Infarct
Funder
National Health and Medical Research Council
Funding Amount
$105,388.00
Summary
Stroke is a major cause of death and disability in our community. Most strokes result from a blocked blood vessel in the brain which leads to the almost immediate death of some brain tissue. However surrounding brain tissue is potentially salvageable if blood supply can be restored. This research uses magnetic resonance imaging (MRI) to better demonstrate salvageable brain tissue so that existing treatments to re-open blocked blood vessels can in future be safer and more widely applicable.